Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

squamosamide

Known as: Benzeneacetamide, 4-hydroxy-alpha-((4-hydroxy-3-methoxyphenyl)methylene)-N-(2-(4-hydroxyphenyl)ethyl)-3,5-dimethoxy-, (E)- 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Parkinson's disease (PD) is a neurodegenerative disease affecting up to 80% of dopaminergic neurons in the nigrostriatal pathway… Expand
2013
2013
The participation of neuroinflammation in the pathogenesis of Parkinson's disease (PD) has long been validated. Excessive… Expand
Highly Cited
2010
Highly Cited
2010
  • N. Li, G. Liu
  • Acta Pharmacologica Sinica
  • 2010
  • Corpus ID: 9028557
AbstractAim:The aim of this study was to study the effects of compound FLZ, a novel cyclic derivative of squamosamide from Annona… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 6
2009
2009
AbstractAim:The aim of this study was to investigate the effect of the squamosamide derivative FLZ (N-2-(4-hydroxy-phenyl)-ethyl… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 5
2008
2008
BackgroundInflammation plays an important role in the pathogenesis of Parkinson's disease (PD) through over-activation of… Expand
2008
2008
AbstractAim:The aim of the present study was to investigate the protective effect of compound N-[2-(4-hydroxy-phenyl)-ethyl]-2-(2… Expand
  • figure 1
  • table 2
  • table 1
  • figure 2
  • table 3
2007
2007
Compound FLZ (cFLZ) is a synthetic novel derivative of natural squamosamide. Previous pharmacological study found that cFLZ… Expand
2007
2007
Compound FLZ is a synthetic novel derivative of squamosamide. Previous pharmacological study found that FLZ improved the abnormal… Expand
2007
2007
  • F. Fang, G. Liu
  • Basic & clinical pharmacology & toxicology
  • 2007
  • Corpus ID: 37748813
The aim of the present study was to access the protective effect of a novel synthesized squamosamide cyclic analogue, compound… Expand
2004
2004
OBJECTIVE To design and synthesize a series of squamosamide cyclic analogues and to test their antioxidation activity. METHODS… Expand